MSLN and neoplasm: Another potential target for CAR molecule development is Mesothelin, a tumor differentiation glycoprotein that is involved in cell adhesion, which is normally expressed on the mesothelial cells but is overexpressed in several solid neoplasms including TNBC [64,65].